Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Vascular complications of diabetes: mechanisms of injury and protective factors.

Rask-Madsen C, King GL.

Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012. Review.

2.

Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.

Obrosova IG, Julius UA.

Curr Vasc Pharmacol. 2005 Jul;3(3):267-83. Review.

PMID:
16026323
3.

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Yamagishi S, Imaizumi T.

Curr Pharm Des. 2005;11(18):2279-99. Review.

PMID:
16022668
4.

Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy.

Elahy M, Baindur-Hudson S, Cruzat VF, Newsholme P, Dass CR.

J Endocrinol. 2014 Sep;222(3):R129-39. doi: 10.1530/JOE-14-0065. Epub 2014 Jun 13. Review.

5.

Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.

Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y, Imaizumi T.

Curr Drug Targets. 2008 Nov;9(11):1025-9. Review.

PMID:
18991613
6.

Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.

Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S.

Curr Pharm Des. 2008;14(10):962-8. Review.

PMID:
18473846
7.

Diabetic retinopathy: A comprehensive review.

Shah CA.

Indian J Med Sci. 2008 Dec;62(12):500-19. Review.

PMID:
19265246
8.

Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.

Yamagishi S, Nakamura K, Matsui T, Noda Y, Imaizumi T.

Curr Pharm Des. 2008;14(5):487-95. Review.

PMID:
18289075
9.

Clinical diabetic nephropathy: natural history and complications.

Grenfell A, Watkins PJ.

Clin Endocrinol Metab. 1986 Nov;15(4):783-805. Review.

PMID:
3536200
10.

Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW.

Curr Drug Targets. 2005 Jun;6(4):511-24. Review.

PMID:
16026270
11.

Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease.

Calderón-Salinas JV, Muñoz-Reyes EG, Guerrero-Romero JF, Rodríguez-Morán M, Bracho-Riquelme RL, Carrera-Gracia MA, Quintanar-Escorza MA.

Mol Cell Biochem. 2011 Nov;357(1-2):171-9. doi: 10.1007/s11010-011-0887-1. Epub 2011 May 28.

PMID:
21625956
12.

Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.

Yamagishi S, Fukami K, Ueda S, Okuda S.

Curr Drug Targets. 2007 Aug;8(8):952-9. Review.

PMID:
17691932
13.

Diabetic retinopathy--biomolecules and multiple pathophysiology.

Ahsan H.

Diabetes Metab Syndr. 2015 Jan-Mar;9(1):51-4. doi: 10.1016/j.dsx.2014.09.011. Epub 2014 Oct 24. Review.

PMID:
25450817
14.

Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients.

Tai TY, Tseng CH, Sung SM, Huang RF, Chen CZ, Tsai SH.

J Formos Med Assoc. 1991 Oct;90(10):936-40.

PMID:
1685173
15.
16.

Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

Kaul K, Hodgkinson A, Tarr JM, Kohner EM, Chibber R.

Curr Diabetes Rev. 2010 Sep;6(5):294-303. Review.

PMID:
20594163
17.

α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes.

Zhang L, Dong L, Liu X, Jiang Y, Zhang L, Zhang X, Li X, Zhang Y.

PLoS One. 2014 Apr 2;9(4):e93433. doi: 10.1371/journal.pone.0093433. eCollection 2014.

18.
19.

AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.

Chilelli NC, Burlina S, Lapolla A.

Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9. doi: 10.1016/j.numecd.2013.04.004. Epub 2013 Jun 17. Review.

PMID:
23786818
20.

Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.

Yamagishi S, Nakamura K, Matsui T.

Curr Drug Discov Technol. 2006 Mar;3(1):83-8. Review.

PMID:
16712466

Supplemental Content

Support Center